New Alzheimer's drug enters first human testing phase
NCT ID NCT07489599
Summary
This is the first human study of an experimental drug called QLH2405 for Alzheimer's disease. Researchers will test single injections in 68 healthy volunteers and people with early Alzheimer's or mild memory problems to check safety and how the body processes the drug. The study focuses on establishing basic safety before testing whether the drug actually helps with memory or thinking.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MILD COGNITIVE IMPAIRMENT(MCI) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.